SCHEMBL29306451

SCHEMBL29306451

CCCCCNS(=O)(=O)Cc1ccon1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ HTT P42858 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ PPARA Q07869 2/20 0.39
▸ RECQL P46063 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CA1 P00915 2/20 0.37
▸ CA2 P00918 2/20 0.37
▸ RELA Q04206 4/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ EPHX1 P07099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23133069 0.95 ATM (0.44) HPGDATMALDH1A1CA12CA9
SCHEMBL24845990 0.82 ALDH1A1 (0.37) HPGDATMALDH1A1HTTMEN1
SCHEMBL12854162 0.73 KCNN4 (0.33) ATMALDH1A1CYP1A2CYP2C19
SCHEMBL1221781 0.71 KCNH2 (0.48) ATMALDH1A1LMNAPPARAKDM4E
SCHEMBL20209685 0.70 KCNH2 (0.52) ATMALDH1A1LMNAPPARAKDM4E
SCHEMBL21186452 0.70 KCNH2 (0.52) ATMALDH1A1LMNAPPARAKDM4E
SCHEMBL21645767 0.70 KCNH2 (0.52) ATMALDH1A1LMNAPPARAKDM4E
SCHEMBL635209 0.69 ALDH1A1 (0.74) HPGDALDH1A1CA12CA9HTT
SCHEMBL694651 0.68 PPARA (0.60) ALDH1A1CA12CA9MEN1KMT2A
SCHEMBL635950 0.68 ALDH1A1 (0.72) HPGDALDH1A1CA12CA9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226026-A1 BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ARES CAPITAL CORPORATION, AS AGENT 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226026-A1 BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS PLTP, LNPK, PLIN3 HPGD 4492/4885ATM 3574/4885ALDH1A1 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback